AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in ...

Millions of Americans rely daily on this type of heart-helping medication. See if this newly provided alert impacts your ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

Sage, thank you for taking the time to speak with us today. What are the most promising industries you're seeing grow in our state right now?

TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.

According to Benzinga Pro, Teva Pharmaceutical Indus's peer group average for short interest as a percentage of float is 3.59 ...

Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.